MX9704388A - Incremento de la concentracion de creatina y glicogeno en musculos. - Google Patents
Incremento de la concentracion de creatina y glicogeno en musculos.Info
- Publication number
- MX9704388A MX9704388A MX9704388A MX9704388A MX9704388A MX 9704388 A MX9704388 A MX 9704388A MX 9704388 A MX9704388 A MX 9704388A MX 9704388 A MX9704388 A MX 9704388A MX 9704388 A MX9704388 A MX 9704388A
- Authority
- MX
- Mexico
- Prior art keywords
- muscle
- creatine
- increasing
- concentration
- insulin
- Prior art date
Links
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title abstract 8
- 229960003624 creatine Drugs 0.000 title abstract 4
- 239000006046 creatine Substances 0.000 title abstract 4
- 229920002527 Glycogen Polymers 0.000 title abstract 3
- 229940096919 glycogen Drugs 0.000 title abstract 3
- 210000003205 muscle Anatomy 0.000 title abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 210000002381 plasma Anatomy 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Se presentan métodos y composiciones para incrementar la retencion de creatina y las concentraciones de glicogeno en musculos del cuerpo humano y/o animal, que comprende el incremento de la concentracion de creatina en el plasma sanguíneos de un cuerpo y que provee un incremento sustancialmente simultáneo de la concentracion de insulina en el plasma sanguíneo. Composiciones que comprenden creatina o bien un derivado activo de la misma se introducen en el cuerpo mediante ingestion oral o bien infusion, como por ejemplo inyeccion, junto con un carbohidrato, como por ejemplo glucosa para incrementar la liberacion de insulina en la sangre que a su ven lleva la glucosa en los musculos para la síntesis del glicogeno. La insulina o bien un derivado activo de la misma puede también encontrarse en la composicion ya sea junto con el carbohidrato o bien en lugar del carbohidrato.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425514.8A GB9425514D0 (en) | 1994-12-17 | 1994-12-17 | Retention of creatine in the body |
| GB9425514.8 | 1994-12-17 | ||
| GB9517443.9 | 1995-08-25 | ||
| GBGB9517443.9A GB9517443D0 (en) | 1994-12-17 | 1995-08-25 | Increasing creatine and glycogen concentration in muscle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9704388A true MX9704388A (es) | 1998-07-31 |
| MXPA97004388A MXPA97004388A (es) | 1998-11-09 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| ATE194462T1 (de) | 2000-07-15 |
| EP0798971A1 (en) | 1997-10-08 |
| GB9517443D0 (en) | 1995-10-25 |
| EP0798971B1 (en) | 2000-07-12 |
| AU4185696A (en) | 1996-07-03 |
| CA2208047A1 (en) | 1996-06-20 |
| DE69518008D1 (de) | 2000-08-17 |
| CA2208047C (en) | 2003-07-15 |
| US5968900A (en) | 1999-10-19 |
| PT798971E (pt) | 2000-12-29 |
| DE69518008T2 (de) | 2001-05-17 |
| WO1996018313A1 (en) | 1996-06-20 |
| ES2150020T3 (es) | 2000-11-16 |
| DK0798971T3 (da) | 2000-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2208047A1 (en) | Increasing creatine and glycogen concentration in muscle | |
| ES2569949T3 (es) | Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina | |
| CO4700482A1 (es) | Formulaciones de un analogo monomero de insulina | |
| IL82209A0 (en) | Insulin preparation | |
| GB0500787D0 (en) | Integration of meningococcal conjugate vaccination | |
| PT1146896E (pt) | Formulacoes monodispersas de analogo acilado e hexamerico insulina | |
| AU1519799A (en) | Salicylate derivatized therapeutic and diagnostic agents | |
| DE69131352T2 (de) | Steigerung des glutathionspiegels durch glutamin | |
| KR900007424A (ko) | 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물 | |
| ES2060685T3 (es) | Medicamento con contenido de azelastina con liberacion controlada del principio activo. | |
| SE9001906L (sv) | Ny anvaendning foer glukos | |
| CA2113856A1 (en) | Antidiabetic Agent | |
| WO2001005955A3 (en) | Animals comprising human hepatocellular tissue | |
| AU6207196A (en) | Composition and method for treating prostate cancer | |
| AU6432899A (en) | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
| WO2003084459A3 (en) | Device for infusing insulin | |
| TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
| EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
| Yu | Chemically-modified tetracycline: absorption, serum half-life, and effect on collagen metabolism | |
| Grasso et al. | Blood substitute on the market | |
| Kozlov | The effect of carbon dioxide gas on the content of ammonia, glutamine, and urea in the blood of amimals after injection of solutions of ammonium chloride | |
| UA29106A (uk) | Спосіб лікування вібраційної хвороби | |
| MD1135F1 (en) | Paradontium treatment method | |
| UA63016C2 (en) | Infusion solution glucsil for parenteral alimentation | |
| Khomenko et al. | Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid |